1.Connecting past and present: single-cell lineage tracing.
Cheng CHEN ; Yuanxin LIAO ; Guangdun PENG
Protein & Cell 2022;13(11):790-807
Central to the core principle of cell theory, depicting cells' history, state and fate is a fundamental goal in modern biology. By leveraging clonal analysis and single-cell RNA-seq technologies, single-cell lineage tracing provides new opportunities to interrogate both cell states and lineage histories. During the past few years, many strategies to achieve lineage tracing at single-cell resolution have been developed, and three of them (integration barcodes, polylox barcodes, and CRISPR barcodes) are noteworthy as they are amenable in experimentally tractable systems. Although the above strategies have been demonstrated in animal development and stem cell research, much care and effort are still required to implement these methods. Here we review the development of single-cell lineage tracing, major characteristics of the cell barcoding strategies, applications, as well as technical considerations and limitations, providing a guide to choose or improve the single-cell barcoding lineage tracing.
Animals
;
Cell Lineage/genetics*
;
Clustered Regularly Interspaced Short Palindromic Repeats
2.Cell lineage tracing of regenerating cells after partial pancreatectomy using pseudo-type retrovirus.
Lixin ZHANG ; Xiaofang JU ; Fa WANG ; Zhiwei GUO ; Shanhua PIAO ; Chunbo TENG
Chinese Journal of Biotechnology 2008;24(4):604-609
Pancreas is an important mixed gland having both endocrine and exocrine functions, and has been proven regeneration after injury. To explore the cell lineage tracing methods in pancreas in vivo and the regenerate cells source, we used pseudo-type retrovirus to transfect adult mouse pancreas which had been partially pancreatectomized by rubbing the kerf using a cotton stick saturated with retrovirus suspension then injecting 100 microL retrovirus suspension into pancreas, injecting 100 microL retrovirus by caudal vein, or interperitoneally injecting retrovirus respectively. The results showed that the method of rubbing the kerf then injection of retrovirus suspension into pancreas could more effectively mark the pancreatic cells than the caudal vein injection and the intraperitoneal injection did in vivo. Furthermore, this study also found that some acinus cells could accept injury stimulus signals to regenerate through resuming mitosis after pancreatic injury. This study establishes a cell lineage tracing method in pancreas in vivo using retrovirus and offers a clue for gene therapy of pancreatic diseases using retrovirus vectors.
Animals
;
Cell Differentiation
;
Cell Lineage
;
Mice
;
Mice, Inbred ICR
;
Pancreas
;
cytology
;
physiology
;
surgery
;
Pancreatectomy
;
methods
;
Regeneration
;
Retroviridae
;
genetics
3.Transitions between epithelial and mesenchymal states during cell fate conversions.
Xiang LI ; Duanqing PEI ; Hui ZHENG
Protein & Cell 2014;5(8):580-591
Cell fate conversion is considered as the changing of one type of cells to another type including somatic cell reprogramming (de-differentiation), differentiation, and trans-differentiation. Epithelial and mesenchymal cells are two major types of cells and the transitions between these two cell states as epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) have been observed during multiple cell fate conversions including embryonic development, tumor progression and somatic cell reprogramming. In addition, MET and sequential EMT-MET during the generation of induced pluripotent stem cells (iPSC) from fibroblasts have been reported recently. Such observation is consistent with multiple rounds of sequential EMT-MET during embryonic development which could be considered as a reversed process of reprogramming at least partially. Therefore in current review, we briefly discussed the potential roles played by EMT, MET, or even sequential EMT-MET during different kinds of cell fate conversions. We also provided some preliminary hypotheses on the mechanisms that connect cell state transitions and cell fate conversions based on results collected from cell cycle, epigenetic regulation, and stemness acquisition.
Animals
;
Cell Differentiation
;
Cell Lineage
;
Cellular Reprogramming
;
Epigenesis, Genetic
;
genetics
;
Epithelial-Mesenchymal Transition
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
4.Delineating nuclear reprogramming.
Protein & Cell 2012;3(5):329-345
Nuclear reprogramming is described as a molecular switch, triggered by the conversion of one cell type to another. Several key experiments in the past century have provided insight into the field of nuclear reprogramming. Previously deemed impossible, this research area is now brimming with new findings and developments. In this review, we aim to give a historical perspective on how the notion of nuclear reprogramming was established, describing main experiments that were performed, including (1) somatic cell nuclear transfer, (2) exposure to cell extracts and cell fusion, and (3) transcription factor induced lineage switch. Ultimately, we focus on (4) transcription factor induced pluripotency, as initiated by a landmark discovery in 2006, where the process of converting somatic cells to a pluripotent state was narrowed down to four transcription factors. The conception that somatic cells possess the capacity to revert to an immature status brings about huge clinical implications including personalized therapy, drug screening and disease modeling. Although this technology has potential to revolutionize the medical field, it is still impeded by technical and biological obstacles. This review describes the effervescent changes in this field, addresses bottlenecks hindering its advancement and in conclusion, applies the latest findings to overcome these issues.
Animals
;
Cell Fusion
;
Cell Lineage
;
genetics
;
Cellular Reprogramming
;
genetics
;
Humans
;
Nuclear Transfer Techniques
;
Pluripotent Stem Cells
;
cytology
;
metabolism
;
Transcription Factors
;
metabolism
5.Distribution of abnormal cell clone with deletion of chromosome 20q in marrow cell lineages and apoptosis cells in myelodysplastic syndrome.
Ling QIN ; Chun WANG ; You-Wen QIN ; Kuang-Cheng XIE ; Shi-Ke YAN ; Yan-Rong GAO ; Xiao-Rui WANG ; Chu-Xian ZHAO
Journal of Experimental Hematology 2008;16(3):551-554
This study was aimed to investigate the distribution of abnormal clone in marrow cell lineages and apoptosis cells in myelodysplastic syndrome (MDS) with deletion of chromosome 20q. Monoclonal antibodies recognizing myeloid precursors (CD15), erythroid precursors (GPA), T cells (CD3(+)CD56(-)CD16(-)), B cells (CD19), NK cells (CD3(-)CD56(+)CD16(+)) were used to sort bone marrow cells in a MDS patient with del (20q) by fluorescence activated cell sorting (FACS). Annexin V-FITC and PI were used to sort bone marrow Annexin V(+)PI(-) and Annexin V(-)PI(-) cells by FACS. The sorted positive cells were detected by interphase dual-color fluorescence in situ hybridization (D-FISH) using a LSI D20S108 probe (Spectrum Orange) and a Telvysion TM 20p probe (Spectrum Green). FACS and FISH analysis were also performed on the samples from 4 cases with normal karyotype. The results showed that the proportions of MDS clone in the myeloid and erythroid precursors were 70.50% and 93.33% respectively, in the RAEB-1 patient with del (20q) and were obviously higher than that in control group (5.39% and 6.17%). The proportions of abnormal clone in T, B and NK cells were 3.23%, 4.32% and 5.77% respectively and were less than that in control group (5.76%, 4.85%, 6.36%). The percentage of apoptotic cells in the bone marrow nucleated cells was 16.09%. The proportions of MDS clone in Annexin V(+)PI(-) and Annexin V(-)PI(-) cells were 32.48% and 70.11%, respectively. It is concluded that most myeloid and erythroid precursors are originated from the abnormal clone in MDS with del (20q). A little part of apoptotic cells are derived from the abnormal clone.
Apoptosis
;
genetics
;
Bone Marrow Cells
;
metabolism
;
pathology
;
Cell Lineage
;
genetics
;
Chromosome Deletion
;
Chromosomes, Human, Pair 20
;
Clone Cells
;
metabolism
;
pathology
;
Humans
;
Myelodysplastic Syndromes
;
genetics
;
pathology
6.Establishment of immortalized B-lymphoblastoid cell lines of keloid pedigree and its karyotype analysis.
Mei SONG ; Jian-hua GAO ; Xin YAN ; Xiao-jun LIU ; Yang CHEN
Journal of Southern Medical University 2006;26(12):1760-1762
OBJECTIVETo establish immortalized B-lymphoblastoid cell lines of keloid pedigree transformed with Epstein-Barr (EB) virus and conduct karyotype analysis of the cells.
METHODSImmortalized B-lymphoblastoid cell lines were established by EB virus transformation of the peripheral blood B lymphocytes from the members of keloid pedigree. Karyotype analysis was performed for the cultured cells of passages 10, 20, 30, and 35 to evaluate their genetic stability.
RESULTSAltogether 27 immortalized lymphoblastoid cell lines with stable chromosome were obtained successfully from the keloid pedigree. No chromosomal abnormalities were found in the cultured cells until passages 30 and 35, in which variation in chromosome number and structure are detected.
CONCLUSIONThe cell lines of the keloid pedigree established in this study can be useful in future studies, and genetic analysis is conducted preferably with cells of early passages.
B-Lymphocytes ; cytology ; metabolism ; virology ; Cell Line, Transformed ; Cell Lineage ; Cell Transformation, Viral ; Female ; Herpesvirus 4, Human ; physiology ; Humans ; Karyotyping ; Keloid ; genetics ; pathology ; Male
7.Two Cases of Near-Tetraploidy in Acute Leukemias of Ambiguous Lineage.
Bo Hyun KIM ; Hye Ryoun KIM ; Mi Kyung LEE ; HyunYoung CHI
Annals of Laboratory Medicine 2013;33(5):371-374
No abstract available.
Acute Disease
;
Aged
;
Aged, 80 and over
;
Bone Marrow Cells/cytology/metabolism/pathology
;
Cell Lineage
;
Humans
;
Immunophenotyping
;
Karyotyping
;
Leukemia/*genetics/metabolism/pathology
;
Male
;
*Tetraploidy
8.Developmental changes in hematopoietic stem cell properties.
Michael R COPLEY ; Connie J EAVES
Experimental & Molecular Medicine 2013;45(11):e55-
Hematopoietic stem cells (HSCs) comprise a rare population of cells that can regenerate and maintain lifelong blood cell production. This functionality is achieved through their ability to undergo many divisions without activating a poised, but latent, capacity for differentiation into multiple blood cell types. Throughout life, HSCs undergo sequential changes in several key properties. These affect mechanisms that regulate the self-renewal, turnover and differentiation of HSCs as well as the properties of the committed progenitors and terminally differentiated cells derived from them. Recent findings point to the Lin28b-let-7 pathway as a master regulator of many of these changes with important implications for the clinical use of HSCs for marrow rescue and gene therapy, as well as furthering our understanding of the different pathogenesis of childhood and adult-onset leukemia.
Animals
;
Cell Differentiation
;
*Cell Lineage
;
Embryonic Stem Cells/cytology/*metabolism
;
HMGA2 Protein/genetics/metabolism
;
Hematopoietic Stem Cells/cytology/*metabolism
;
Humans
;
Leukemia/etiology/metabolism/surgery
;
MicroRNAs/genetics/metabolism
;
RNA-Binding Proteins/genetics/metabolism
9.Genetic controls of Th17 cell differentiation and plasticity.
Experimental & Molecular Medicine 2011;43(1):1-6
CD4+ T lymphocytes play a major role in regulation of adaptive immunity. Upon activation, naive T cells differentiate into different functional subsets. In addition to the classical Th1 and Th2 cells, several novel effector T cell subsets have been recently identified, including Th17 cells. There has been rapid progress in characterizing the development and function of Th17 cells. Here I summarize and discuss on the genetic controls of their differentiation and emerging evidence on their plasticity. This information may benefit understanding and treating immune diseases.
Animals
;
CD4-Positive T-Lymphocytes/cytology/*immunology
;
Cell Differentiation
;
Cell Lineage
;
Cytokines/*genetics
;
Epigenesis, Genetic
;
Gene Expression Regulation
;
Humans
;
Interleukin-17/immunology/metabolism
;
T-Lymphocytes, Regulatory
;
Th1 Cells/immunology
;
Th17 Cells/*immunology
;
Th2 Cells/immunology
;
Transcription Factors/*genetics
;
Transcription, Genetic
10.Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities.
Xiao-Ming LIU ; Li ZHANG ; Min RUAN ; Tian-Feng LIU ; Jia-Yuan ZHANG ; Fang LIU ; Ben-Quan QI ; Xiao-Juan CHEN ; Shu-Chun WANG ; Wen-Yu YANG ; Ye GUO ; Yao ZOU ; Yu-Mei CHEN ; Xiao-Fan ZHU
Chinese Journal of Contemporary Pediatrics 2016;18(4):287-291
OBJECTIVETo identify the incidence of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia (B-ALL) without reproducible chromosomal abnormalities and to investigate the association between PAX5 abnormalities and prognosis of ALL.
METHODSMultiplex ligation-dependent probe amplification was used to determine the copy numbers of PAX5 gene in children newly diagnosed with B-ALL without reproducible chromosomal abnormalities between April 2008 and April 2013 and controls (children with non-hematologic diseases or tumors). The patients were classifiied into deletion group and non-deletion group based on the presence of PAX5 deletion.
RESULTSEighteen (21%) out of 86 children with B-ALL had PAX5 deletion. The deletion group had a significantly higher total white blood cell count at diagnosis than the non-deletion group (P=0.001). The Kaplan-Meier analysis demonstrated that the deletion group had a significantly lower disease-free survival (DFS) rate than the non-deletion group (0.69±0.12 vs 0.90±0.04; P=0.017), but there was no significant difference in the overall survival rate between the two groups (P=0.128). The Cox analysis showed that PAX5 deletion was a risk factor for DFS (P=0.03).
CONCLUSIONSPAX5 deletion is an independent risk factor for DFS in B-ALL children without reproducible chromosomal abnormalities.
Acute Disease ; Adolescent ; Cell Lineage ; Child ; Child, Preschool ; Chromosome Aberrations ; Disease-Free Survival ; Female ; Gene Deletion ; Humans ; Infant ; Male ; PAX5 Transcription Factor ; genetics ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; mortality